Practical guideline for the management of allergic rhinitis in Japan 2024

Auris Nasus Larynx. 2025 Aug;52(4):426-441. doi: 10.1016/j.anl.2025.05.005. Epub 2025 Jun 21.

Abstract

The Practical Guideline for the Management of Allergic Rhinitis in Japan was first published in 1993. After the COVID-19 pandemic, the current 10th edition was published in 2024. The most recent collection of evidence from the literature, such as the sustained post-treatment effect of sublingual immunotherapy on Japanese cedar pollinosis, was added to the revised guideline, which incorporates evidence-based medicine. In this revised guideline, a diagram illustrating the pathogenesis of allergic rhinitis and the mechanisms of action of various pharmacological treatments has been added. Also included is a diagram that shows the mechanism of action of allergen immunotherapy and a more detailed description of the oral allergy syndrome. The clinical question and answer section was also revised along with the introduction of new questions, such as: Does anti-IgE antibody treatment effectively reduce the symptoms of severe seasonal allergic rhinitis? Also updated was the evidence-based step-by-step strategy for treatment.

Keywords: Allergic rhinitis; Guideline; Mechanism of action of pharmacotherapy; Pollinosis; Sublingual immunotherapy.

Publication types

  • Practice Guideline

MeSH terms

  • COVID-19 / epidemiology
  • Desensitization, Immunologic
  • Humans
  • Japan
  • Rhinitis, Allergic* / therapy
  • Rhinitis, Allergic, Seasonal* / therapy
  • SARS-CoV-2
  • Sublingual Immunotherapy